$EXPO
EXPONENT INC

2016 Q2 Form 10-Q Financial Statement

#000114420416099622 Filed on May 06, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $83.16M $80.29M
YoY Change 3.57% 5.7%
Cost Of Revenue $4.200M $4.200M
YoY Change 0.0% 40.0%
Gross Profit $79.00M $76.10M
YoY Change 3.81% 4.25%
Gross Profit Margin 95.0% 94.78%
Selling, General & Admin $55.50M $54.60M
YoY Change 1.65% 3.8%
% of Gross Profit 70.25% 71.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400M $1.400M
YoY Change 0.0% 7.69%
% of Gross Profit 1.77% 1.84%
Operating Expenses $66.72M $65.27M
YoY Change 2.23% 5.49%
Operating Profit $16.44M $15.03M
YoY Change 9.37% 6.63%
Interest Expense $100.0K $0.00
YoY Change
% of Operating Profit 0.61% 0.0%
Other Income/Expense, Net $1.298M $2.043M
YoY Change -36.47% 60.74%
Pretax Income $17.73M $17.07M
YoY Change 3.88% 11.1%
Income Tax $2.384M $6.738M
% Of Pretax Income 13.44% 39.47%
Net Earnings $15.35M $10.33M
YoY Change 48.55% 12.88%
Net Earnings / Revenue 18.46% 12.87%
Basic Earnings Per Share $0.58 $0.39
Diluted Earnings Per Share $0.56 $0.38
COMMON SHARES
Basic Shares Outstanding 26.51M shares 26.62M shares
Diluted Shares Outstanding 27.24M shares 27.39M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $155.0M $145.0M
YoY Change 6.9% 5.45%
Cash & Equivalents $98.54M $123.7M
Short-Term Investments $56.50M $21.40M
Other Short-Term Assets $11.70M $23.70M
YoY Change -50.63% -12.87%
Inventory
Prepaid Expenses
Receivables $94.90M $88.08M
Other Receivables $0.00 $0.00
Total Short-Term Assets $261.7M $256.8M
YoY Change 1.9% 2.88%
LONG-TERM ASSETS
Property, Plant & Equipment $28.50M $27.59M
YoY Change 3.31% -2.57%
Goodwill $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.70M $1.159M
YoY Change 6690.34% 95.45%
Total Long-Term Assets $115.7M $100.4M
YoY Change 15.22% 8.73%
TOTAL ASSETS
Total Short-Term Assets $261.7M $256.8M
Total Long-Term Assets $115.7M $100.4M
Total Assets $377.4M $357.2M
YoY Change 5.64% 4.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.200M $8.900M
YoY Change -7.87% -31.01%
Accrued Expenses $40.00M $40.20M
YoY Change -0.5% -4.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $54.70M $54.88M
YoY Change -0.32% -12.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.10M $1.985M
YoY Change 2423.93% 58.8%
Total Long-Term Liabilities $50.10M $1.985M
YoY Change 2423.93% 58.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.70M $54.88M
Total Long-Term Liabilities $50.10M $1.985M
Total Liabilities $104.9M $103.4M
YoY Change 1.43% 3.01%
SHAREHOLDERS EQUITY
Retained Earnings $273.5M $248.1M
YoY Change 10.25% 9.97%
Common Stock $174.2M
YoY Change 11.86%
Preferred Stock
YoY Change
Treasury Stock (at cost) $189.2M $167.0M
YoY Change 13.3% 19.41%
Treasury Stock Shares 6.899M shares 3.436M shares
Shareholders Equity $272.5M $253.8M
YoY Change
Total Liabilities & Shareholders Equity $377.4M $357.2M
YoY Change 5.64% 4.46%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $15.35M $10.33M
YoY Change 48.55% 12.88%
Depreciation, Depletion And Amortization $1.400M $1.400M
YoY Change 0.0% 7.69%
Cash From Operating Activities $300.0K $1.700M
YoY Change -82.35% -127.87%
INVESTING ACTIVITIES
Capital Expenditures $1.481M $627.0K
YoY Change 136.2% -31.48%
Acquisitions
YoY Change
Other Investing Activities -$10.60M $3.300M
YoY Change -421.21% 200.0%
Cash From Investing Activities -$12.00M $2.700M
YoY Change -544.44% 1250.0%
FINANCING ACTIVITIES
Cash Dividend Paid $4.628M $4.023M
YoY Change 15.04% 21.54%
Common Stock Issuance & Retirement, Net $3.500M $3.500M
YoY Change 0.0% -48.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.40M -10.10M
YoY Change 52.48% -12.93%
NET CHANGE
Cash From Operating Activities 300.0K 1.700M
Cash From Investing Activities -12.00M 2.700M
Cash From Financing Activities -15.40M -10.10M
Net Change In Cash -27.10M -5.700M
YoY Change 375.44% -67.43%
FREE CASH FLOW
Cash From Operating Activities $300.0K $1.700M
Capital Expenditures $1.481M $627.0K
Free Cash Flow -$1.181M $1.073M
YoY Change -210.07% -115.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
78950000 USD
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
76141000 USD
CY2015Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
4152000 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
15350000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
10333000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26513000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26622000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27239000 shares
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1740000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179816000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
269259000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
273524000 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
184499000 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
189247000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
262804000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
272540000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-65000 USD
CY2016Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
4206000 USD
CY2016Q2 us-gaap Revenues
Revenues
83156000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1159000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2009000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17734000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17071000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2384000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6738000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
85000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000 USD
CY2015Q2 us-gaap Revenues
Revenues
80293000 USD
CY2016Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
52017000 USD
CY2015Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6510000 USD
CY2016Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4206000 USD
CY2015Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4152000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3514000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3488000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16436000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15028000 USD
CY2016Q2 us-gaap Investment Income Net
InvestmentIncomeNet
139000 USD
CY2015Q2 us-gaap Investment Income Net
InvestmentIncomeNet
34000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-501000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15430000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9825000 USD
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1403000 USD
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1381000 USD
CY2016Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-22000 USD
CY2015Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-213000 USD
CY2016Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-110000 USD
CY2015Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-145000 USD
CY2016Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
434000 USD
CY2015Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
390000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5220000 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5221000 USD
CY2016Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-430000 USD
CY2015Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1938000 USD
CY2016Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4431000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6769000 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2098000 USD
CY2016Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-728000 USD
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2689000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2300000 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4553000 USD
CY2016Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11944000 USD
CY2015Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12017000 USD
CY2016Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1291000 USD
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2450000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
313000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1701000 USD
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1481000 USD
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
627000 USD
CY2016Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
1450000 USD
CY2015Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
3320000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12031000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2693000 USD
CY2016Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4431000 USD
CY2016Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7613000 USD
CY2015Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7267000 USD
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3500000 USD
CY2015Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3500000 USD
CY2016Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
305000 USD
CY2015Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
289000 USD
CY2016Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
4628000 USD
CY2015Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
4023000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-15436000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-10070000 USD
CY2016Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-62000 USD
CY2015Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-156000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27216000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5832000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129490000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123658000 USD
CY2016Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
12000000 USD
CY2016Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1001000 USD
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
390000 USD
CY2016Q1 us-gaap Assets
Assets
387507000 USD
CY2015Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6169000 USD
CY2016Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
223000 USD
CY2015Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
12028000 USD
CY2016Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
111778000 USD
CY2016Q2 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
52122000 USD
CY2016Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
52122000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10530000 USD
CY2016Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
99312000 USD
CY2016Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
46740000 USD
CY2016Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
46740000 USD
CY2016Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
18479000 USD
CY2016Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
38000000 USD
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
56479000 USD
CY2016Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
18498000 USD
CY2016Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
38014000 USD
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
155014000 USD
CY2016Q2 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
34000 USD
CY2016Q2 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
1000 USD
CY2016Q2 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
155047000 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
171699000 USD
CY2016Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
1000 USD
CY2016Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
107000 USD
CY2016Q2 us-gaap Assets
Assets
377405000 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1725000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1805000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
377405000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
387507000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
65265000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1298000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2043000 USD
CY2016Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
171593000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2016Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
72724 shares
CY2015Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
80966 shares
CY2015Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3500000 USD
CY2016Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
43265000 USD
CY2016Q2 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5791000 USD
CY2015Q2 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4943000 USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3058000 USD
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2792000 USD
CY2016Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2016Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2015Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2016Q2 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2016Q1 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2016Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2016Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016Q2 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2016Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4628000 USD
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
6899000 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7133000 shares
CY2016Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2016Q2 expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2016Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3500000 USD
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.60

Files In Submission

Name View Source Status
0001144204-16-099622-index-headers.html Edgar Link pending
0001144204-16-099622-index.html Edgar Link pending
0001144204-16-099622.txt Edgar Link pending
0001144204-16-099622-xbrl.zip Edgar Link pending
expo-20160401.xml Edgar Link completed
expo-20160401.xsd Edgar Link pending
expo-20160401_cal.xml Edgar Link unprocessable
expo-20160401_def.xml Edgar Link unprocessable
expo-20160401_lab.xml Edgar Link unprocessable
expo-20160401_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v437767_10q.htm Edgar Link pending
v437767_ex31-1.htm Edgar Link pending
v437767_ex31-2.htm Edgar Link pending
v437767_ex32-1.htm Edgar Link pending
v437767_ex32-2.htm Edgar Link pending